Autologous marrow transplantation in acute lymphoblastic leukemia: control of residual disease with mafosfamide and induction of syngeneic GVHD with cyclosporin. The Italian Mafosfamide Study Group.
Rizzoli
V
V
Bone Marrow Transplantation Unit, University of Parma, Italy.
Carella
A M
AM
Carlo-Stella
C
C
Mangoni
L
L
D000293:Adolescent; D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use; D016026:Bone Marrow Transplantation / Q000276:immunology; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000031:analogs & derivatives* / Q000627:therapeutic use; D003524:Cyclosporins / Q000627:therapeutic use; D005260:Female; D006086:Graft vs Host Disease / Q000209:etiology* / Q000276:immunology; D006801:Humans; D008297:Male; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy / Q000276:immunology / Q000601:surgery*; D014182:Transplantation, Autologous
D000970:Antineoplastic Agents; D003524:Cyclosporins; C048341:mafosfamide; D003520:Cyclophosphamide